Home/Filings/4/0001600620-23-000038
4//SEC Filing

Bailey Jeffrey Allen 4

Accession 0001600620-23-000038

CIK 0001600620other

Filed

Aug 20, 8:00 PM ET

Accepted

Aug 21, 4:25 PM ET

Size

7.4 KB

Accession

0001600620-23-000038

Insider Transaction Report

Form 4
Period: 2023-08-18
Transactions
  • Award

    Restricted Stock Units

    2023-08-18+17,91317,913 total
    Common Stock (17,913 underlying)
  • Award

    Stock Option (right to buy)

    2023-08-18+28,95928,959 total
    Exercise: $9.49Exp: 2033-08-18Common Stock (28,959 underlying)
Footnotes (2)
  • [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest one year from date of grant and have no expiration date. Vested shares will be delivered on August 18, 2024.
  • [F2]The option vests in twelve equal monthly installments commencing on September 18, 2023.

Issuer

Aurinia Pharmaceuticals Inc.

CIK 0001600620

Entity typeother

Related Parties

1
  • filerCIK 0001500210

Filing Metadata

Form type
4
Filed
Aug 20, 8:00 PM ET
Accepted
Aug 21, 4:25 PM ET
Size
7.4 KB